Bloomberg Businessweek

Blackstone Life Sciences, which has some $17 billion in assets under management, typically invests in late-stage medicines invented by biotech and pharmaceutical companies in exchange for a royalty on future sales. In 2024, for example, the firm invested as much as $750 million in financing for Moderna’s flu vaccine development.

But Blackstone also wants to own a stake in some companies that it backs.
In late March, Blackstone closed its latest life-sciences fund with $6.3 billion of commitments, the firm’s biggest haul for backing clinical trials of medicines and technologies.

Dr. Jenny Rooke is Founder and Managing Director of Genoa Ventures. She discusses the cross between tech and health with Carol Massar and Tim Stenovec.
See omnystudio.com/listener for privacy information.

Featuring some of our favorite conversations of the week from our daily radio show “Bloomberg Businessweek Daily.”

Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.

Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW
See omnystudio.com/listener for privacy information.

The people, companies and trends shaping the global economy.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Businessweek visited Three Mile Island and went inside the training facility preparing for the the plant to come back online as soon as mid-2027. Thanks to a long-term agreement signed by Microsoft Corp. and Constellation Energy Corp. in September 2024, the energy from the plant will power chatbots and other artificial intelligence applications.
All this under a new and baggage-free name: the Crane Clean Energy Center. The agreement commits Microsoft to buying all the electricity produced by the site’s remaining functional 835-megawatt reactor for 20 years.

Today's show features:
Will Wade, Bloomberg Energy Reporter on how Microsoft's vast power demands are bringing together two transformative—and risky—technologies
Christel Rendu de Lint, co-CEO at Vontobel
Daniel Barcelo, Chairman and CEO at T1 Energy on state of energy industry
Michael Gross, SLR Capital Partners Co-Founder and James Crombie, Bloomberg Senior Editor for Credit on state of Private Credit
Meenakshi Lala, CEO at UrbanStems
See omnystudio.com/listener for privacy information.

While today's devices put the world’s information at our fingertips, they do not help us with some of the cognitive skills that are arguably more important to leading a successful life. Combining psychology, artificial intelligence, human computer interaction and neuroscience, the Fluid Interfaces group designs, develops and tests systems and experiences for supporting motivation, attention, memory, learning, creativity, critical thinking, reasoning, communication, sleep quality and emotion regulation.
Dr. Pattie Maes is Professor of Media Arts & Sciences AND Head of Fluid Interfaces Group at the MIT Media Lab. She discusses the intersection between human psychology and large language models.
See omnystudio.com/listener for privacy information.

The people, companies and trends shaping the global economy.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Elanco Animal Health recently reported upbeat results showing market gains against their key rival in the animal health space, Zoetis. Hosts Carol and Tim speak with Elanco president and CEO Jeff Simmons about the company's earnings and how the animal health industry could serve as a bellwether for consumer health.
Today's show features:
Jeff Simmons, President and CEO at Elanco Animal Health
Gal Krubiner, co-founder and CEO at Pagaya Technologies
Revathi Advaithi, CEO of Flex on Earnings, Spinoff Announcement
See omnystudio.com/listener for privacy information.